Multistep activation of the Helicobacter pylori effector CagA

被引:30
|
作者
Mueller, Anne [1 ]
机构
[1] Univ Zurich, Inst Mol Canc Res, CH-8057 Zurich, Switzerland
来源
JOURNAL OF CLINICAL INVESTIGATION | 2012年 / 122卷 / 04期
关键词
GASTRIC-CANCER; IV SECRETION; PHOSPHORYLATION; INFECTION; KINASE; METAANALYSIS; PROTEIN; DISEASE; RISK; SRC;
D O I
10.1172/JCI61578
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Chronic infection with the Gram-negative bacterium Helicobacter pylori is a major risk factor for the development of gastric cancer. Accumulating evidence indicates that the H. pylori virulence determinant cytotoxin-associated gene A (CagA) has a key oncogenic role in the process. Certain biological activities of CagA require its tyrosine phosphorylation by host cell kinases. In this issue of the JCI, Mueller and colleagues report their detailed kinetic and functional analysis of CagA phosphorylation, which indicates that c-Src and c-Abl kinases sequentially phosphorylate CagA. Interestingly, the two phosphorylation events need not occur on the same CagA molecule but are both required for the biological effects of CagA. The results provide a clinically relevant example of how a successful bacterial pathogen has evolved to exploit the tightly coordinated, sequential activity of host cell kinases for virulence factor activation and induction of pathology.
引用
收藏
页码:1192 / 1195
页数:4
相关论文
共 50 条
  • [1] The Versatility of Helicobacter pylori CagA Effector Protein Functions: The Master Key Hypothesis
    Backert, Steffen
    Tegtmeyer, Nicole
    Selbach, Matthias
    HELICOBACTER, 2010, 15 (03) : 163 - 176
  • [2] Activation of beta-catenin signal by Helicobacter pylori CagA
    Hatakeyama, M.
    Murata-Kamiya, N.
    Kurashima, Y.
    Yamahashi, Y.
    Saito, Y.
    HELICOBACTER, 2006, 11 (04) : 330 - 330
  • [3] Serological differentiation of Helicobacter pylori CagA(+) and CagA(-) infections
    Chmiela, M
    Wisniewska, M
    Bak-Romaniszyn, L
    Rechcinski, T
    Planeta-Malecka, I
    Bielanski, W
    Konturek, SJ
    Plonka, M
    Klink, M
    Rudnicka, W
    ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2003, 51 (02) : 131 - 136
  • [4] Characterizing Helicobacter pylori cagA in Myanmar
    Myint, Thein
    Miftahussurur, Muhammad
    Vilaichone, Ratha-korn
    Ni, New
    Aye, Than Than
    Subsomwong, Phawinee
    Uchida, Tomohisa
    Mahachai, Varocha
    Yamaoka, Yoshio
    GUT AND LIVER, 2018, 12 (01) : 51 - 57
  • [5] Helicobacter Pylori CagA and Gastric Carcinogenesis
    Zheng, Ri-Nan
    Li, Shu-Rong
    Masahiro, Asaka
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (12) : 6305 - 6310
  • [6] SagA of CagA in Helicobacter pylori pathogenesis
    Hatakeyama, Masanori
    CURRENT OPINION IN MICROBIOLOGY, 2008, 11 (01) : 30 - 37
  • [7] cagA and the outcome of Helicobacter pylori infection
    Blaser, MJ
    Crabtree, JE
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 1996, 106 (05) : 565 - 567
  • [8] Identification of the functional role of the bacterial effector and oncoprotein CagA expressed by Helicobacter pylori in immune cells
    Chichirau, B. E.
    Diechler, S.
    Scheidt, T.
    Benedetti, A.
    Freinek, C.
    Posselt, G.
    Wessler, S.
    HELICOBACTER, 2019, 24
  • [9] Role of CEACAM members 1 and 5 in type IV secretion of the effector protein CagA by Helicobacter pylori
    Tegtmeyer, N.
    Backert, S.
    HELICOBACTER, 2019, 24
  • [10] VARIATION IN HELICOBACTER PYLORI CAGA PROMOTER REGION IS ASSOCIATED WITH CAGA EXPRESSION
    Ferreira, R. M.
    Machado, J. C.
    Figueiredo, C.
    HELICOBACTER, 2012, 17 : 68 - 68